Infection and Immunity

Edit Your Profile

Infection and Immunity Journal

publication venue for

RNA Sequencing Reveals Distinct Immune Responses in the Chorioamniotic Membranes of Women with Preterm Labor and Microbial or Sterile Intra-amniotic Inflammation. 89. 2021
Exoenzyme S ADP-ribosylates Rab5 effector sites to uncouple intracellular trafficking.. 82:21-28. 2014
Regulation of Rab5 Function during Phagocytosis of Live Pseudomonas aeruginosa in Macrophages. 81:2426-2436. 2013
Multifunctional Role of Human SPLUNC1 in Pseudomonas aeruginosa Infection. 81:285-291. 2013
Identification of Cytokeratin 18 as a Biomarker of Mouse and Human Hepatosplenic Schistosomiasis. 79:2051-2058. 2011
Differential Patterns of Liver Proteins in Experimental Murine Hepatosplenic Schistosomiasis. 78:618-628. 2010
Discriminating Virulence Mechanisms among Bacillus anthracis Strains by Using a Murine Subcutaneous Infection Model. 77:429-435. 2009
Cerebrospinal fluid-infiltrating CD4+ T cells recognize Borrelia burgdorferi lysine-enriched protein domains and central nervous system autoantigens in early lyme encephalitis. 75:243-251. 2007
Differential binding of host complement inhibitor factor H by Borrelia burgdorferi Erp surface proteins: A possible mechanism underlying the expansive host range of Lyme disease spirochetes. 70:491-497. 2002
ADP-ribosylation of Rab5 by ExoS of Pseudomonas aeruginosa affects endocytosis. 69:5329-5334. 2001
Borrelia burgdorferi RevA antigen is a surface-exposed outer membrane protein whose expression is regulated in response to environmental temperature and pH. 69:5286-5293. 2001
Distinct regulatory pathways control expression of Borrelia burgdorferi infection-associated OspC and Erp surface proteins. 69:4146-4153. 2001
Lipopolysaccharide complexes with Pasteurella haemolytica leukotoxin. 67:2920-2927. 1999
Stability of erp loci during Borrelia burgdorferi infection: Recombination is not required for chronic infection of immunocompetent mice. 67:3146-3150. 1999
Development of two monoclonal antibodies against Plasmodium falciparum sporozoite surface protein 2 and mapping of B-cell epitopes. 65:3430-3437. 1997
Identification of a nonameric H-2K(k)-restricted CD8+ cytotoxic T lymphocyte epitope on the Plasmodium falciparum circumsporozoite protein. 63:1955-1959. 1995
A chemically synthesized peptide which elicits humoral and cellular immune responses to mycobacterial antigens. 53:560-564. 1986
A completely synthetic toxoid vaccine containing Escherichia coli heat-stable toxin and antigenic determinants of the heat-labile toxin B subunit. 48:735-740. 1985
Mucosal antitoxin response in volunteers to immunization with a synthetic peptide of Escherichia coli heat-stable enterotoxin. 50:328-332. 1985
Differences in cross-protection in rats immunized with the B subunits of cholera toxin and Escherichia coli heat-labile toxin. 43:811-816. 1984
Properties of cross-linked toxoid vaccines made with hyperantigenic forms of synthetic Escherichia coli heat-stable toxin. 44:268-273. 1984
Immunological properties of purified Klebsiella pneumoniae heat-stable enterotoxin. 42:838-841. 1983
Properties of synthetically produced Escherichia coli heat-stable enterotoxin. 39:117-121. 1983
Protection against human and porcine enterotoxigenic strains of Escherichia coli in rats immunized with a cross-linked toxoid vaccine. 40:924-929. 1983
Protection in rabbits immunized with a vaccine of Escherichia coli heat-stable toxin cross-linked to the heat-labile toxin B subunit. 40:888-893. 1983
MODIFIED HEMOLYTIC PLAQUE TECHNIQUE FOR DETECTION OF BLUETONGUE VIRUS ANTIBODY-FORMING-CELLS. 13:1321-1324. 1976
Calcium requirement and magnesium stimulation of Escherichia coli L-form induction.. 6:880-882. 1972

category

IMMUNOLOGY Category
INFECTIOUS DISEASES Category

International Standard Serial Number (ISSN)

0019-9567